pyrroles has been researched along with tacrolimus in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 5 (14.71) | 29.6817 |
| 2010's | 26 (76.47) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Hioki, K; Kameshita, I; Mohri, T; Suzuki, S; Takatani, S; Tokunaga, R | 1 |
| Andreka, P; Bishopric, NH; Evans, WH; Haywood, GA; Martin, PE; Turner, MS; Webster, KA; You, L | 1 |
| Asberg, A; Hermann, M; Holdaas, H; Lemahieu, WP; Maes, BD; Vanrenterghem, Y; Verbeke, K | 1 |
| Abramowicz, D; Berkenboom, G; Broeders, N; Carpentier, Y; Ghisdal, L; Unger, P; Wissing, KM | 1 |
| Hoskova, L; Kautzner, J; Kubanek, M; Malek, I; Podzimkova, M; Skalicka, B; Vymetalova, Y | 1 |
| Brennan, DC; Bromberg, JS; Busque, S; Chan, G; Fisher, RA; Hariharan, S; Klintmalm, G; Lawendy, N; Leventhal, J; Mulgaonkar, S; Peddi, VR; Shah, T; Slakey, D; Steinberg, S; Vincenti, F; Wang, C | 1 |
| Asderakis, A; Barten, MJ; Becker, T; Budde, K; Dantal, J; Grinyo, JM; Ng, J; Pietruck, F; Rigotti, P; Sommerer, C; Weber, M | 1 |
| Grenet, O; Kovarik, JM; Seiberling, M; Sfikas, N; Slade, A; Stitah, S; Straube, F; Vitaliti, A; Winter, S | 1 |
| Fang, YH; Jeong, HJ; Joo, DJ; Kim, JY; Kim, MS; Kim, YS; Lim, BJ | 1 |
| Amundsen, R; Asberg, A; Christensen, H; Zabihyan, B | 1 |
| Busque, S; Chan, G; Krishnaswami, S; Lamba, M; Melcher, M; Tafti, B | 1 |
| Haron, MM; Houssen, ME; Ibrahim, TM; Metwally, SS | 1 |
| Brunet, M; Cofán, F; Cofán, M; Guillén, D; Millán, O; Ros, E | 1 |
| Budde, K; Glander, P; Mashreghi, MF; Matz, M; Naik, M; Neumayer, HH | 1 |
| Arns, W; Budde, K; Dantal, J; Grinyo, JM; Kovarik, JM; Proot, P; Rostaing, L; Steiger, JU | 1 |
| Abrams, K; Arns, W; Banas, B; Budde, K; Chan, L; Cibrik, D; Friman, S; Klempnauer, J; Mulgaonkar, S; Nashan, B; Nicholson, M; Vincenti, F; Wahlberg, J; Wissing, KM; Witte, S; Woodle, ES | 1 |
| Fang, YH; Huh, KH; Joo, DJ; Kim, MS; Kim, YS; Lim, BJ; Suh, H | 1 |
| Corcione, N; Di Pace, AL; Ferraro, P; Giordano, A; Monaco, M; Nappo, G; Polimeno, M; Romano, MF; Romano, S; Sorrentino, A | 1 |
| Baan, CC; Chan, G; Kho, MM; Mol, WM; Quaedackers, ME; Vafadari, R; Weimar, W | 1 |
| Broscheit, C; Egli, A; Humar, A; Kumar, D; O'Shea, D | 1 |
| Beckebaum, S; Cicinnati, VR; Kabar, I; Radtke, A | 1 |
| Baan, CC; Kraaijeveld, R; Vafadari, R; Weimar, W | 1 |
| Budde, K; Chodoff, L; Cohney, S; Eris, J; Gill, J; Klupp, J; Kuypers, DR; Langer, RM; Ng, J; Russ, GR; Sommerer, C; Tedesco-Silva, H; von Zur-Mühlen, B; Witzke, O; Woodle, ES | 1 |
| Bossart, W; Etter, A; Fehr, T; Hässig, A; Müller, N; Roos, M; Schiesser, M; Wüthrich, RP | 1 |
| Ikari, K; Inoue, E; Ishida, O; Koenuma, N; Koyama, T; Momohara, S; Ochi, K; Sakuma, Y; Taniguchi, A; Yamanaka, H; Yano, K; Yoshida, S | 1 |
| Bijarnia, M; De Simone, P; Isoneimi, H; Klupp, J; Krishnan, I; Pascher, A; Pirenne, J; Pratschke, J; Salamé, E | 1 |
| Karam, S; Wali, RK | 1 |
| Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
| Aguiar, W; Campos, E; Cristelli, M; Felipe, C; Ferreira, A; Franco, M; Gerbase de Lima, M; Hannun, P; Medina-Pestana, J; Sandes-Freitas, T; Tedesco-Silva, H | 1 |
| Hirose, J; Inami, M; Ito, M; Morio, H; Morokata, T; Nakamura, K; Noto, T; Okuma, K; Shirakami, S | 1 |
| Fukahori, H; Hanaoka, K; Hirose, J; Inami, M; Ito, M; Kaneko, Y; Kawato, Y; Kubo, K; Maeda, M; Morokata, T; Nakamura, K; Nakanishi, T; Noto, T | 1 |
| Fukahori, H; Hamakawa, N; Hirose, J; Inami, M; Maeda, M; Morio, H; Morokata, T; Nakamura, K; Nakanishi, T; Noto, T; Oshima, S; Tsujimoto, S | 1 |
| Jian, X; Kan, B; Kong, L; Ning, Q; Ren, Y; Zhang, Z | 1 |
| Araki, M; Ariyoshi, N; Kitagawa, M; Kitamura, S; Kobayashi, Y; Kubota, R; Maruyama, Y; Matsumoto, J; Mitsui, Y; Morinaga, H; Nasu, Y; Nishimura, S; Sadahira, T; Sekito, T; Sugiyama, H; Takeuchi, H; Tanabe, K; Wada, J; Wada, K; Watanabe, M; Watanabe, T; Watari, S; Yoshinaga, K | 1 |
3 review(s) available for pyrroles and tacrolimus
| Article | Year |
|---|---|
Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.
Topics: Calcineurin Inhibitors; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Sirolimus; Tacrolimus; Treatment Outcome | 2011 |
Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors?
Topics: Abatacept; Calcineurin Inhibitors; Everolimus; Humans; Immunoconjugates; Immunosuppression Therapy; Liver Transplantation; Mycophenolic Acid; Precision Medicine; Pyrroles; Quinazolines; Renal Insufficiency; Risk Factors; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2013 |
Current State of Immunosuppression: Past, Present, and Future.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Marrow Transplantation; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus | 2015 |
12 trial(s) available for pyrroles and tacrolimus
| Article | Year |
|---|---|
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus.
Topics: Area Under Curve; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Indoles; Lactones; Liver; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pravastatin; Pyrroles; Simvastatin; Tacrolimus; Time Factors | 2005 |
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
Topics: Adult; Apolipoproteins; Atorvastatin; Body Mass Index; Creatinine; Cross-Over Studies; Drug Therapy, Combination; Endothelium, Vascular; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Pyrroles; Tacrolimus; Triglycerides | 2006 |
Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Biopsy; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Janus Kinases; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Piperidines; Pyrimidines; Pyrroles; Tacrolimus; Transplantation, Homologous; Young Adult | 2009 |
Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients.
Topics: Adult; Aged; Biopsy; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Tacrolimus; Treatment Outcome | 2010 |
Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses.
Topics: Adult; Area Under Curve; Biomarkers; Calcium; Cell Proliferation; Cross-Over Studies; Drug Interactions; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Lymphocytes; Male; Protein Kinase C; Pyrroles; Quinazolines; RNA, Messenger; T-Lymphocytes; Tacrolimus; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Population pharmacokinetic analysis of mycophenolic acid coadministered with either tasocitinib (CP-690,550) or tacrolimus in adult renal allograft recipients.
Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Models, Biological; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Tacrolimus | 2010 |
Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients.
Topics: Adenosine Triphosphate; Adult; Aged; Atorvastatin; Biomarkers; Cell Proliferation; Culture Media, Conditioned; Cytokines; Female; Gene Expression Regulation; Heptanoic Acids; Humans; Hypercholesterolemia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pyrroles; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Tacrolimus; Transplantation | 2010 |
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Pyrroles; Quinazolines; Tacrolimus; Treatment Outcome; Young Adult | 2011 |
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
Topics: Adult; Calcineurin Inhibitors; Female; Humans; Kidney Transplantation; Male; Mycophenolic Acid; Protein Kinase C; Pyrroles; Quinazolines; Tacrolimus | 2011 |
Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients.
Topics: Antibodies, Monoclonal; Basiliximab; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Interleukin-15; Interleukin-2; Interleukin-7; Janus Kinases; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Count; Lymphocytes; Netherlands; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptors, Interleukin-2; Recombinant Fusion Proteins; Signal Transduction; STAT5 Transcription Factor; Tacrolimus; Time Factors; Treatment Outcome | 2012 |
Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results.
Topics: Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Immunosuppressive Agents; Kidney; Kidney Transplantation; Pyrroles; Quinazolines; Retrospective Studies; Tacrolimus; Treatment Outcome | 2013 |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial.
Topics: Adult; Aged; Biopsy; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Liver Failure; Liver Transplantation; Male; Middle Aged; Protein Kinase C; Pyrroles; Quinazolines; Tacrolimus; Time Factors; Treatment Outcome | 2015 |
19 other study(ies) available for pyrroles and tacrolimus
| Article | Year |
|---|---|
Rapid adhesion and spread of non-adherent colon cancer Colo201 cells induced by the protein kinase inhibitors, K252a and KT5720 and suppression of the adhesion by the immunosuppressants FK506 and cyclosporin A.
Topics: Adenocarcinoma; Carbazoles; Cell Adhesion; Cell Adhesion Molecules; Colonic Neoplasms; Cyclosporine; Cytoskeletal Proteins; Enzyme Inhibitors; Extracellular Matrix; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunosuppressive Agents; Indole Alkaloids; Indoles; Integrins; Neoplasm Metastasis; Paxillin; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Pyrroles; Sulfonamides; Tacrolimus; Tumor Cells, Cultured; Tyrosine | 1998 |
Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels.
Topics: Adenosine Triphosphate; Alkaloids; Aminoimidazole Carboxamide; Animals; Antimycin A; Benzophenanthridines; Brefeldin A; Carbazoles; Cell Hypoxia; Cells, Cultured; Connexin 43; Cycloheximide; Deoxyglucose; Flavonoids; Imidazoles; Indoles; JNK Mitogen-Activated Protein Kinases; Maleimides; Myocardial Contraction; Myocytes, Cardiac; Okadaic Acid; Ouabain; Phenanthridines; Phosphorylation; Potassium Cyanide; Protein Processing, Post-Translational; Pyridines; Pyrroles; Rats; Recombinant Fusion Proteins; Ribonucleotides; Staurosporine; Tacrolimus; Tetradecanoylphorbol Acetate | 2004 |
Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Heart Transplantation; Heptanoic Acids; Humans; Immunosuppressive Agents; Indoles; Male; Middle Aged; Prospective Studies; Pyrroles; Tacrolimus; Treatment Outcome; Triglycerides | 2009 |
AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: a preliminary report.
Topics: Animals; Graft Rejection; Graft Survival; Heart Transplantation; Lymphocyte Activation; Male; Myocardial Contraction; Pyrroles; Quinazolines; Rats; Rats, Inbred BN; Rats, Inbred Lew; T-Lymphocytes; Tacrolimus; Transplantation, Heterotopic; Transplantation, Homologous | 2010 |
Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin.
Topics: Atorvastatin; Cell Line; Cyclosporine; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Organic Anion Transporters; Pyrroles; Tacrolimus | 2010 |
Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis.
Topics: Animals; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Heptanoic Acids; Immunologic Factors; Inflammation; Interferon-gamma; Interleukin-6; Male; Plasma; Pyrroles; Rabbits; Tacrolimus; Triglycerides | 2011 |
The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
Topics: Acute Disease; Animals; Disease Models, Animal; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Kidney; Liver; Male; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Rats; Rats, Inbred BN; Rats, Inbred Lew; Tacrolimus; Transplantation, Heterotopic; Transplantation, Homologous | 2011 |
Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells.
Topics: Aged; Aged, 80 and over; Antigens, CD; Atorvastatin; beta Catenin; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Cyclin B; DNA Replication; Dose-Response Relationship, Drug; Drug-Eluting Stents; Endoglin; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Pyrroles; Receptors, Cell Surface; Tacrolimus; Time Factors | 2012 |
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling.
Topics: Abatacept; Adult; Cytokines; Cytomegalovirus; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Humans; Immunoconjugates; Immunosuppressive Agents; In Vitro Techniques; Middle Aged; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Sirolimus; T-Lymphocytes; Tacrolimus; Th1 Cells; Th2 Cells; Transcriptome | 2013 |
Tacrolimus inhibits NF-κB activation in peripheral human T cells.
Topics: Calcineurin Inhibitors; Cells, Cultured; Cytokines; Humans; Immunosuppressive Agents; NF-kappa B; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Pyrroles; Quinazolines; Signal Transduction; T-Lymphocytes; Tacrolimus | 2013 |
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Topics: Adult; Aged; Allografts; Antibodies, Monoclonal; Azathioprine; Basiliximab; BK Virus; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Polyomavirus Infections; Proteinuria; Pyrroles; Quinazolines; Recombinant Fusion Proteins; Tacrolimus; Tumor Virus Infections; Viremia | 2014 |
Recent trends in orthopedic surgery aiming to improve quality of life for those with rheumatoid arthritis: data from a large observational cohort.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cohort Studies; Databases, Factual; Female; Humans; Japan; Joints; Male; Orthopedic Procedures; Piperidines; Pyrimidines; Pyrroles; Quality of Life; Sulfonamides; Tacrolimus | 2014 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Efficacy and Safety of Elective Conversion From Sotrastaurin (STN) to Tacrolimus (TAC) or Mycophenolate (MPS) in Stable Kidney Transplant Recipients.
Topics: Adult; Antibodies; Cohort Studies; Drug Interactions; Drug Substitution; Everolimus; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Pyrroles; Quinazolines; Tacrolimus | 2016 |
AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts.
Topics: Allografts; Animals; Cell Count; Cell Proliferation; Drug Interactions; Graft Rejection; Heart Transplantation; Humans; Janus Kinases; Piperidines; Protein Kinase Inhibitors; Pyrroles; Reticulocytes; Tacrolimus; Time Factors | 2017 |
Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model.
Topics: Allografts; Animals; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Graft Rejection; Humans; Interleukin-6; Janus Kinases; Kidney Transplantation; Piperidines; Pyrroles; Rats; Rats, Inbred Lew; Tacrolimus | 2018 |
Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
Topics: Animals; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Macaca fascicularis; Male; Mycophenolic Acid; Piperidines; Pyrroles; Tacrolimus; Transplantation, Homologous | 2018 |
Effects of tacrolimus on the TGF‑β1/SMAD signaling pathway in paraquat‑exposed rat alveolar type II epithelial cells.
Topics: Alveolar Epithelial Cells; Animals; Cell Line; Cell Proliferation; Cell Survival; Herbicides; Immunosuppressive Agents; Paraquat; Pulmonary Fibrosis; Pyrazoles; Pyrroles; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Signal Transduction; Smad3 Protein; Smad7 Protein; Tacrolimus; Transforming Growth Factor beta1 | 2020 |
Blood concentrations of tacrolimus upon conversion from rabeprazole to vonoprazan in renal transplant recipients: Correlation with cytochrome P450 gene polymorphisms.
Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Genotype; Immunosuppressive Agents; Kidney Transplantation; Polymorphism, Genetic; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides; Tacrolimus | 2021 |